Humana Executive Compensation (FY25)
HUM · Executive and director compensation, fiscal 2022 to 2025
The Humana brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of September 12, 2026Latest filing (8-K): April 20, 2026
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
331 figures on this page: 322 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — James Rechtin: $15,579,476 → $18,757,075 (20.4% higher)
Say-on-pay support: 89.4% → 95.4% (6.0 points higher)
CEO pay ratio: 195:1 → 226.2:1 (16.0% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Humana's chief executive and what were they paid?
James Rechtin was paid $18,757,075 in total compensation as President and Chief Executive Officer for fiscal 2025. Rechtin's total was 20.4% higher than the $15,579,476 reported for fiscal 2024.
What was Humana's say-on-pay result?
Shareholders supported the say-on-pay proposal with 95.4% of votes cast for or against in favor at the meeting held April 16, 2026 for fiscal 2025.
Which companies are in Humana's peer group?
The disclosed peer group names Aflac, Inc., Allstate Corporation, Cardinal Health, Inc., Cencora and Centene Corporation, among others.
What is Humana's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 226.2:1, against median employee compensation of $82,935.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Bruce Broussard Former Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Susan Diamond Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Joseph Ventura Chief Legal Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Bruce Broussard Former Chief Executive Officer | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Susan Diamond Former Chief Financial Officer | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Sanjay Shetty President, CenterWell | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | ◇ |
Joseph Ventura Chief Legal Officer | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
George Renaudin President, Insurance | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
David Dintenfass President, Enterprise Growth | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
James Rechtin President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Bruce Broussard Former Chief Executive Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Susan Diamond Former Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Sanjay Shetty President, CenterWell | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
George Renaudin President, Insurance | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Celeste Mellet Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
James Rechtin President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Japan Mehta Chief Information Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Michelle O'Hara Chief Human Resources Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Sanjay Shetty President, CenterWell | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Susan Diamond Former Chief Financial Officer Departed during or after this year | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Celeste Mellet | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Celeste Mellet | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Celeste Mellet | PSU | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ |
| James Rechtin | PSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| James Rechtin | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Japan Mehta | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Japan Mehta | PSU | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ |
| Japan Mehta | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michelle O'Hara | — | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michelle O'Hara | PSU | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ |
| Michelle O'Hara | EQUITY | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sanjay Shetty | PSU | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ |
| Sanjay Shetty | RSU | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sanjay Shetty | PSU | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ |
| Susan Diamond | EQUITY | ◇ | — | — | ◇ | — | — | — |
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Susan Diamond | Option | ◇ | — | ◇ | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Japan Mehta | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| James Rechtin | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| PSU | ◇ | ◇ | — | — | |
| Michelle O'Hara | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Sanjay Shetty | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| Celeste Mellet | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Kurt J. Hilzinger Board chair | ◇ | ◇ | — | — | — | ◇ | ◇ |
Karen W. Katz | ◇ | ◇ | — | — | — | ◇ | ◇ |
Wayne A. I. Frederick, M.D | ◇ | ◇ | — | — | — | ◇ | ◇ |
Marcy S. Klevorn | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jorge S. Mesquita | ◇ | ◇ | — | — | — | ◇ | ◇ |
Frank A. D'Amelio | ◇ | ◇ | — | — | — | ◇ | ◇ |
Raquel C. Bono, M.D | ◇ | ◇ | — | — | — | ◇ | ◇ |
David T. Feinberg, M.D | ◇ | ◇ | — | — | — | ◇ | ◇ |
John W. Garratt | ◇ | ◇ | — | — | — | ◇ | ◇ |
Gordon Smith | ◇ | ◇ | — | — | — | — | ◇ |
Brad D. Smith | ◇ | ◇ | — | — | — | ◇ | ◇ |
James A. Rechtin served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x annual cash retainer
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Aflac, Inc. AFL
- Allstate Corporation ALL
- Cardinal Health, Inc. CAH
- Cencora COR
- Centene Corporation CNC
- CVS Health Corp CVS
- DaVita Inc. DVA
- Elevance Health, Inc. ELV
- HCA Healthcare, Inc. HCA
- Laboratory Corporation of America Holdings, Inc. symbol not shown
- McKesson Corp MCK
- MetLife, Inc. MET
- Molina Healthcare MOH
- Progressive Corporation PGR
- Prudential Financial, Inc. PRU
- The Cigna Group CI
- UnitedHealth Group Inc. UNH
- Walgreens Boots Alliance, Inc. WBA
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | April 16, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | April 17, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | April 18, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | April 20, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | April 21, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | April 22, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | April 23, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | April 18, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | April 19, 2018 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Humana disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Humana sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
331 figures on this page: 322 cited to the filing that reported them, 9 calculated from figures it prints.
322 cited to the filing
9 calculated from the filing
Documents cited
- 0000049071-26-000015Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001104659-26-024799CEO Pay Ratio Calculation · Director Compensation · Outstanding Equity Awards at Fiscal Year-End · Summary Compensation Table
- 0000049071-25-000016Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-25-048976Summary Compensation Table
- 0000049071-24-000017
- 0001193125-24-062915Summary Compensation Table
- 0000049071-23-000018
- 0001193125-23-063813Summary Compensation Table
- 0000049071-22-000026
- 0000049071-21-000074
- 0000049071-20-000078
- 0001193125-19-112123
- 0001193125-18-126812
- 0001104659-26-024393COMPENSATION COMMITTEE · FOR THE REASONS STATED HEREIN, THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKH
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Humana executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/HUM (accessed 2026).
Short form: data: Velarion
The Humana brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Humana and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Humana discloses
The companies named in HUM's own disclosed peer group.
Aflac, Inc.Allstate CorporationCardinal Health, Inc.CencoraCentene CorporationCVS Health CorpDaVita Inc.Elevance Health, Inc.HCA Healthcare, Inc.McKesson CorpMetLife, Inc.Molina HealthcareProgressive CorporationPrudential Financial, Inc.The Cigna GroupUnitedHealth Group Inc.Walgreens Boots Alliance, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}